Henry Schein Inc. (HSIC) continues to provoke interest among investors and financial stakeholders, with recent actions indicating mixed signals. The company's potential for consistent earnings has been touted, alongside a significant acquisition of HSIC shares by
First Citizens Bank & Trust Co. However, a downgrade to 'Sell' from CFRA is concerning, with expectations of better performance in pharmaceutical distributors.
Henry Schein's dental business expansion contributes to stock gains, despite macroeconomic difficulties. Several insiders sold a huge amount of stock, which could signal a potential weakness. HSIC is also enhancing its customer support by proactively setting up
assistance hotlines ahead of hurricanes. Even though HSIC shows strength despite cyber threats and global economic issues, Zacks Research predicts a negative outlook for the company's Q3 earnings. With its new product launches and investment commitments,
HSIC is expected to see a stock boost. Approximately $20.35 million of HSIC stock is held by
Marathon Asset Management Ltd. Lastly, Henry Schein's social efforts resulted in the company being named to FORTUNE® Magazine’s ‘Change the World’ list.
Henry Schein HSIC News Analytics from Fri, 11 Mar 2022 08:00:00 GMT to Sat, 19 Oct 2024 13:39:30 GMT -
Rating 1
- Innovation -7
- Information 3
- Rumor 2
